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Cold atmospheric plasma (CAP) is a rapidly developed technology that has been
widely applied in biomedicine especially in cancer treatment. Due to the generation
of various active species in plasma, CAP could induce various tumor cells death and
showed a promising potential in cancer therapy. To enhance the biological effects of gas
plasma, changing the discharging parameters is the most commonly used method, yet
increasing discharging power will lead to a higher possibility of simultaneously dam-
age surrounding tissues. In this study, by adding nontoxic concentration of additional
nitrite and nitrate in the medium, we found that anti-tumor effect of CAP treatment
was enhanced in the same discharging parameters. By microplate reader and cell
flow cytometer we measured several extracellular and intracellular RONS and found
that ONOO- was mostly correlated with the enhanced cancer cell killing effect. We
proposed that more nitrogen supplies such as nitrite and nitrate could increase the
production of RNS especially ONOO- and resulted in a better killing effect to can-
cer cells. Our results provided a new strategy to enhance the antitumor effect by
plasma jet treatment without changing the discharging parameters. © 2018 Author(s).
All article content, except where otherwise noted, is licensed under a Creative
Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
https://doi.org/10.1063/1.5046353
I. INTRODUCTION
Plasma, which is often regarded as the fourth state of material besides solid, liquid and gas,
is mainly consisted of free electron and charged ions. The emergence of cold atmosphere plasma
(CAP) makes it possible to study the influence on cells and biological tissues due to its generation
under atmospheric pressure at low temperature.1,2 Thus, plasma medicine has become a hot topic
in interdisciplinary courses recently, including sterilization, dentistry, cosmetology, wound healing,
dermology application and cancer therapy.3–5 CAPs could efficiently induce various tumor cells
death, and by far it is considered that the generation of reactive oxygen species (ROS) and reactive
nitrogen species (RNS) in plasma are the main factors.6 Among these species, hydroxyl radical (OH),
hydrogen peroxide (H2O2), ozone (O3), superoxide anion (O2−), nitric oxide (NO), and peroxynitrite
anion (ONOO−) are the main components related to biological effects induced by CAPs.7–9 Hirst
AM et al. reported that H2O2 formed in the medium after CAP treatment was a facilitator of DNA
damage and cell death.10 Naresh Kumar et al. found that deuterium oxide (DO) generated from CAP
aThese authors contributed equally to this work.
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could induce apoptosis on melanocytes G361 tumor cells via DNA damage signaling cascade.11
Yan X et al. showed that plasma induced NO accumulation resulted in more effective lipid peroxidation
and finally, HepG2 cell death.7 Our previous work found that O2− and H2O2 induced by CAP could
convert to the highly reactive OH radical with the presence of iron containing proteins, thus resulting
in myeloma cell death.9 It is reported that RNS was also important in the plasma induced cell death.
Panngom K et al. found that the cytotoxicity to human lung cancer cells was strongly mediated by the
large amount of H2O2 and NOx in medium generated by dielectric barrier discharge (DBD) plasma.8
ONOO– is a potent oxidizing and nitrating specie formed from a diffusion-controlled reaction between
O2− and NO, which could penetrate bilayer lipid membrane and disturb the function of mitochondrion
and consequently influence cell metabolism and cause DNA damage leading to cell death.12–14 Our
previous study also demonstrated the involvement of ONOO– in the induction of apoptosis by N2/O2
plasma jet.15 In normal condition, RNS was produced by plasma mostly through the miscellaneous
air in the ambient environment. In order to give more nitrogen supplies for better production of RNS,
we added additional nitrite and nitrate in the plasma interaction system and found that it had a better
toxic effect in tumor cells. Our results provided a new strategy to enhance the killing effect in tumor
cells by plasma jet treatment.
II. MATERIALS AND METHODS
A. CAP generation system
The CAP used in this study was generated by a plasma jet system consisted of a gas flow
controller, high-voltage power supply, oscilloscope and plasma jet device. A gas flow of 2 slm He
was used at voltages of 10 kHz/8 kV for He plasma generation. Applied voltage, current and average
power were monitored real-time to ensure the stability of the gas plasma.
B. Cell culture and plasma treatment
We utilised the LP-1 multiple myeloma cell16 and Molm-13 human acute myeloid leukemia cell
lines in this study. These cell lines were all grown in Roswell Park Memorial Institute (RPMI) 1640
medium supplemented with 10% foetal calf serum, 100 U/mL penicillin, and 50 µg/mL streptomycin
(Corning, Ithaca, NY, USA). Cells were cultured at 37 ◦C in an incubator (Thermo Scientific Varioskan
Flash, Waltham, MA, USA) containing 5 % CO2. Cells were refreshed 24 h before performing
experiments. For plasma treatment, 2×105 cells were cultured in 24 well plates in 300 µL RPMI1640
complete medium and were treated with plasma jet 1.5 cm away from the bottom of the plates. After
treatment, cells were continually cultured for further experiments.
C. Optical emission spectroscopy
The emission spectra of the plasma was measured using a UV/Visible spectrometer (Maya pro
2000, Ocean Optics, China) within a wavelength range of 200-800 nm. The emission spectra of He
plasma was analyzed in the vertical direction 2 cm in front of the plasma jet.
D. Cell viability assay
The effects of plasma on cell viability of LP-1 and Molm-13 cells were investigated using the
CellTiter-Glo ® Luminescent Cell Viability Assay kit (Promega, Madison, WI, USA), which was
based on the production of ATP in viable cells. CellTiter-Glo® Buffer was mixed with CellTiter-
Glo® Substrate to form the CellTiter-Glo®Reagent before experiment. 100 µL of cell suspension and
100 µL of CellTiter-Glo®Reagent were added to a 96-well opaque plate, then the plate was incubated
at room temperature for 10 min after mixing for 2 min on an orbital shaker. The luminescence was
determined using the microplate reader (Thermo Scientific) with the protocol of “luminometric”
measurement.
E. Measurements of ROS and RNS
Fluorescent probes were used to detect the relevant ROS and RNS in our experiments. DAF-FM
DA (Beyotime Institute of Biotechnology) was used for NO detection,17 Dihydroethidium (DHE,
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Beyotime) for O2− detection18 and Coumarin Boronic Acid (CBA) for ONOO–.19 Cells were treated
with plasma jet for different durations and the extracelluar and intracellular ROS and RNS were
measured 6 h after treatment by adding the fluorescent probes according to the instructions. Cells
were harvested and the suspension was used to detect extracelluar concentration by a microplate
reader (Thermo Scientific) with excitation/emission at 495/515 nm for NO, 535/610 nm for O2− level
and 332/410 nm for ONOO− using the protocol of “Fluorometric” measurement. The cell pellets were
resuspended in 400 µL PBS after washing with 1 mL PBS for 3 times and intracellular fluorescence
was detected by flow cytometry (BD, C6, Franklin Lakes, NJ, USA) with green fluorescence channel
(FL1) for NO, ONOO− and red fluorescence channel (FL3) for O2− level. In addition, peroxynitrite
was purchased from Cayman Chemical (Michigan, Ann Arbor, USA), which could produce ONOO−
and usually supplied as a solution in 3 M NaOH, to investigate the effect of ONOO− in cancer
cells.
F. ROS and RNS scavengers
Several ROS and RNS scavengers were used to distinguish the component efficacy in the plasma.
These scavengers were purchased from Sigma-Aldrich (St. Louis, MO, USA), mainly including
CPTIO for NO;20 Tiron for O2−;21 Ebselen for ONOO−;22,23 and N-acetyl cysteine (NAC) as a
general ROS scavenger.24,25 Scavengers were added prior to plasma treatment to guarantee their
effectiveness at a final concentration of 100 µM for NO; 10 mM for Tiron; 100 nM Ebselen for
ONOO– and 10 µM for NAC.
G. Statistical analysis
All values were presented as mean ± SD of three independent experiments. Differences between
controls and treated groups were evaluated using the Mann-Whitney U test. P<0.05 was considered
statistically significant.
III. RESULTS
A. Characteristics of He plasma generation
He plasma was generated at the voltage of 10 kHz/8 kV with a He gas flow of 2 SLM. Fig. 1(a)
shows the structure of the plasma jet device and photograph of He plasma. Fig. 1(b) shows the
corresponding applied voltage, current and average power during He plasma generation. To investigate
the different reactive species in the plasma, we used a spectrometer to measure the emission spectra.
There were several spectral lines (e.g., OH (A) 309 nm, N2 (C) 337 nm, N2+ (B) 391 nm) presented
in the plasma as shown in Fig. 1(c).
B. Cytotoxicity of NaNO2, NaNO3 and their synergies with plasma on tumor cells
Myeloma LP-1 and leukemia Molm-13 tumor cells were treated with different doses of NaNO2
and NaNO3, and cell viablity was determinated after incubation for 24 h and 48 h. Cell viabil-
ity assay showed that treatment with different doses of NaNO2 (0∼1000 µM) had no effect on
LP-1 (Fig. 2(a)) and Molm-13 (Fig. 2(b)) tumor cells. Similar results were obtained by NaNO3
(0∼1000 µM) treatment in LP-1 (Fig. 2(a)) and Molm-13 (Fig. 2(b)) tumor cells, indicating that
neither NO2− nor NO3− had a cell cytotoxicity to LP-1 and Molm-13 tumor cells. Next, we added
10 µM and 50 µM of NO2− and NO3− (nontoxic concentration) separately prior to He plasma
treatment and investigated whether they could enhance the plasma-induced tumor cell death. The
results showed that both NO2− and NO3− (at two different concentration) could significantly enhance
cell viability reduction that was induced by He plasma in myeloma LP-1 cells (Fig. 2(c)). Simi-
lar results were found in leukemia Molm-13 tumor cells (Fig. 2(d)) that NO2− and NO3− could
enhance the cytotoxity of He plasma treatment. Furthermore, 50 µM of NO2− and NO3− showed
a better synergistic effect with He plasma than that of 10 µM, indicating that providing more
NO2− and NO3− may somehow interact with reactive species in the plasma and result in more cell
death.
105219-4 Xu et al. AIP Advances 8, 105219 (2018)
FIG. 1. Characteristics of the He plasma. (a) Schematic representation of the plasma jet device and the photograph of He
plasma. (b) Monitoring of the applied voltage, current and average power during He plasma generation. (c) Emission spectra
of He plasma detected by the spectrometer. Several unique spectral lines (e.g., OH (A) 309 nm, N2 (C) 337 nm, N2+ (B)
391 nm) in the plasma are marked.
FIG. 2. Cytotoxicity of NaNO2, NaNO3 and their synergies with plasma on tumor cells. (a, b) Cytotoxicity of NaNO2
and NaNO3 with different concentration was measured by cell-titer-glo viability assay in myeloma LP-1 cells (a) and leukemia
Molm-13 cells (b) after incubation for 24 h and 48 h. (c, d) The combination effects of He plasma treatment for 30 s with
nontoxic concentration of NaNO2 and NaNO3 in LP-1 cells (c) and Molm-13 cells (d) determined by cell viability assay 24 h
after treatment. n=3,∗ indicates P < 0.05. ∗∗ indicates P < 0.01.
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C. Detection of NO and O2− levels after plasma treatment and its’ combination
with NaNO2 and NaNO3
As demonstrated in our previous study, NO and O2− are two of the main substrate to pro-
duce ONOO−,26 so we first monitored intracellular and extracellular NO level by He plasma
treatment and the interaction with NaNO2 and NaNO3. As shown in Fig. 3(a), NO level was ele-
vated by plasma treatment in LP-1 myeloma cells and in Molm-13 leukemia cells, while ROS
scanvenger, NAC, could reverse the increasing of the fluorescent intensity. However, the combi-
nation of He plasma with NaNO2 and NaNO3 did not increase the intracellular fluorescent intensity
compared to He plasma alone (Fig. 3(b)). The extracellular NO level was significantly increased
by He plasma treatment for different durations in LP-1 and Molm-13 cells (Fig. 3(c)). These
results showed that NO could be produced by plasma in the liquid and further transferred into the
cells.
We next detected the O2− level by flow cytometer using dihydroethidium dye after plasma
treatment in LP-1 and Molm-13 cells. O2− level was significantly increased after plasma treat-
ment for 60 s in LP-1 and Molm-13 cells while NAC could block the elevation of O2− level
(data not shown). Additional of NaNO2 and NaNO3 did not significantly increase the intracel-
lular O2− level when treated with He plasma for 30 s (Fig. 3(d)). Extracellular O2− level fluo-
rescent intensity was also measured by microplate reader, showed that He plasma treatment for
different durations could significantly increase extracellular O2− level in LP-1 and Molm-13 cells
(Fig. 3(e)).
FIG. 3. Detection of NO and O2− concentration by plasma treatment and nitrite addition. (a)The fluorescence of
intracellular NO was assayed by flow cytometer 6 h after He plasma treatment for 30 s, 60 s or pretreated with 10 mM NAC in
LP-1 and Molm-13 cells. (b) Measurement of intracellular NO levels 6 h after He plasma treatment and its combination with
50 µM of NaNO2 and NaNO3. (c) Extracellular NO levels of LP-1 and Molm-13 cells were detected by microplate reader
6 h after He plasma treatment for 30 s, 60 s and 90 s. NAC group denoted 10 mM of NAC was added prior to 90 s of
He plasma treatment. (d) Measurement of intracellular O2− levels 6 h after He plasma treatment and its combination with
50 µM of NaNO2 and NaNO3. (e) Extracellular O2− levels of LP-1 and Molm-13 cells were detected by microplate reader 6 h
after He plasma treatment for 30 s, 60 s and 90 s. NAC group denoted 10 mM of NAC was added prior to 90 s of He plasma
treatment. n=3,∗ indicates P < 0.05. ∗∗ indicates P < 0.01.
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FIG. 4. Detection of ONOO− concentration and the effects of ROS scavengers on tumor cell viability. (a) ONOO− level
was detected 6 h after He plasma treatment for 30 s, 60 s, and 90 s, with or without cells. (b) Measurement of ONOO− level
6 h after combination treatment of He plasma (30 s/60 s) with 50 µM of NaNO2 and NaNO3 in LP-1 cells. (c) Dose dependent
cell death induced by peroxynitrite in LP-1 and Molm-13 cells. (d, e) Effects of pretreating with scavenger of NO (CPTIO),
O2− (Tiron) and ONOO− (Ebselen) respectively, on the cytotoxicity of LP-1 cells induced by (d) 30 µM of peroxynitrite or
(e) 10 s, 30 s and 60 s of He plasma treatment. n=3,∗ indicates P < 0.05. ∗∗ indicates P < 0.05.
D. Measurement of ONOO- concentration and the effect of ROS scavenger
on tumor cell viability
We quantified the effects of CAP on cellular ONOO− levels of LP-1, Molm-13 cells and RPMI
1640 medium using coumarin boronic acid pinacolate easter, a redox-sensitive fluorescent probe.27,28
The ONOO− levels were all significantly raised with the increase of CAP treatment time while 10 mM
NAC could fully reverse the induction of ONOO− by CAP treatment (Fig. 4(a)). Additionally, ONOO−
level induced by CAP was higher in RPMI 1640 medium than in LP-1 and Molm-13 cells. Fig. 4(b)
showed that ONOO− level in LP-1 cells was promoted by the addition of NaNO2 and NaNO3
compared to 30 s or 60 s of CAP treatment alone. Peroxynitrit, an exogenous ONOO− reagent was
used to test the cytotoxicity of ONOO− to cancer cells. Fig. 4(c) demonstrated that cell viability was
decreased at a dose dependent manner in LP-1 and Molm-13 cells after peroxynitrite treatment for
24 h. According to the references 20–23, we chose Carboxy-PTIO (CPTIO), Tiron and Ebselen as the
inhibitor of NO, O2− and ONOO− respectively. The outcomes showed that cell viability was decreased
after 30 µM of peroxynitrite treatment, and only Ebselen could reverse the effects (Fig. 4(d)). Then,
we detected whether the scavenger of NO, O2− and ONOO− could attenuate CAP-induced tumor cell
death. The results showed that 30 s and 60 s of He plasma treatment had a significant reduction on cell
viability, however, the reduction could partially be abrogated when pretreated with ROS scavengers
especially for Ebselen (Fig. 4(e)).
IV. DISCUSSION
Different ROS and RNS in gas plasma are mostly depended on several aspects, such as: plasma
device and structure, applied voltage, frequency, working and feeding gases, and humidity. In order to
get a better inactivation of tumor cells by plasma, we could increase the applied voltage or frequency
which may directly increase the input power energy. However, the current will simultaneously increase
which might be dangerous in the clinical trials. It is reported that additional O2 in the working gas might
enhance the killing effects of gas plasma on tumor cells, yet O2 is an electric negative gas that will
decrease the intensity of the plasma.29,30 Water vapor in the working gas will increase the generation
of OH which is important to plasma induced cell apoptosis,9 but excess humanity will extinct the
discharging and eliminate the plasma. In our experiments, we observed several unique spectral lines
(e.g., OH (A) 309 nm, N2 (C) 337 nm, N2+ (B) 391 nm) in He plasma, that is because the He plasma
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was produced in the ambient air and some nitrogen and water vapor were mixed in the plasma, such
as water molecules in the air, which should be the source of OH radicals. Besides, in the medium, we
could detect several RONS after He plasma treatment because some of them could directly permeate
from the gas phase to the liquid phase. Some of the species could be generated by second reaction
of these species and also the interaction with liquid. For example, O2- may be produced in air by
electron attachment of oxygen molecules due to the negative affinity of oxygen, and ONOO- may
be generated by the reaction from O2- and NO. In this study, we tried to enhance the effect of gas
plasma by changing the components in the solution. As demonstrated by several groups that ONOO−
is important in plasma induce tumor cell death, we added additional nitrite and nitrate in the medium
to produce more RNS. Indeed, ONOO- could interact with proteins and biological molecular of the
cells, and resulted in a lower concentration of ONOO- level in LP-1 and Molm-13 cells than in RPMI
1640 medium without cells. Furthermore, our results showed that NO2− and NO3− could enhance
the cytotoxity of He plasma treatment on myeloma and leukemia tumor cells by the accumulation of
ONOO−. Girard et al. reported that NO2−, acts in synergy with H2O2 to enhance cell death in normal
and tumor cell lines combined with plasma treatment.31 They assumed that peroxynitric acid can be
formed by the interaction of NaNO2 and H2O2. Peroxynitrite can induce both cellular apoptosis and
necrosis depending on the production rates, endogenous antioxidant levels and exposure time.32 We
have already demonstrated that plasma treatment has a selective inactivation of tumor cells compared
to normal cells, partly because of tumor cells have a higher expression of CD95, which is a target
of plasma treatment.33 Combined with the previous reports that peroxynitrite has an important role
in plasma induced tumor cell death,15,34 This work gives a potential application to enhance plasma
biological effects without changing the plasma discharging parameters or increasing the input power.
In conclusion, we found that additional supplement of NO2− and NO3− could enhance the
cytotoxity of He plasma treatment on myeloma tumor cells without reinforcing the gas plasma
discharging. In addition, the synergistic effects were mostly mediated by the production of ONOO−.
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